Home Cart Sign in  
Chemical Structure| 10030-73-6 Chemical Structure| 10030-73-6

Structure of Palmitelaidic Acid
CAS No.: 10030-73-6

Chemical Structure| 10030-73-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Palmitelaidic Acid (9-trans-Hexadecenoic acid) is the trans isomer of palmitoleic acid. Palmitoleic acid is one of the most abundant fatty acids in serum and tissues.

Synonyms: trans-Palmitoleic acid; 9-trans-Hexadecenoic acid; C16:1 (trans-9) Fatty acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Palmitelaidic Acid

CAS No. :10030-73-6
Formula : C16H30O2
M.W : 254.41
SMILES Code : CCCCCC/C=C/CCCCCCCC(O)=O
Synonyms :
trans-Palmitoleic acid; 9-trans-Hexadecenoic acid; C16:1 (trans-9) Fatty acid
MDL No. :MFCD00067230
InChI Key :SECPZKHBENQXJG-BQYQJAHWSA-N
Pubchem ID :5282745

Safety of Palmitelaidic Acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Palmitelaidic Acid

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 cells 10 µM 14 hours To study the anti-inflammatory activity of 16:1 isomers, it was found that 16:1n-7 and 16:1n-9 exhibited significant anti-inflammatory effects at low concentrations (10 μM), while 16:1n-10 required higher concentrations (>25 μM) to observe similar effects. J Lipid Res. 2018 Feb;59(2):237-249
Human monocytes 10 µM 14 hours To study the anti-inflammatory activity of 16:1 isomers, it was found that 16:1n-7 and 16:1n-9 exhibited significant anti-inflammatory effects at low concentrations (10 μM), while 16:1n-10 required higher concentrations (>25 μM) to observe similar effects. J Lipid Res. 2018 Feb;59(2):237-249
C2C12 myotubes Conditioned medi µM treatment 16 hours To assess the impact of macrophage-conditioned medium on insulin signaling in myotubes. Results demonstrated that CM from palmitic acid-treated macrophages impaired insulin signaling and glycogen synthesis, while palmitoleic acid-mac-CM had insulin-sensitizing effects. Mol Cell Endocrinol. 2014 Aug 5;393(1-2):129-42
BEAS-2B cells 0.5 mg/mL 24 hours To investigate the effect of PMA on P. aeruginosa QS activation and its impact on infection-induced lung injury. Results showed that PMA significantly reduced the concentrations of QS signaling molecules (3OC12-HSL and C4-HSL), pyocyanin production, and transcription levels of QS genes. Respir Res. 2024 Dec 2;25(1):423
3T3-L1 cells 100 µM 24 hours Palmitoleic acid increased the proliferation and differentiation of 3T3-L1 cells, increased lipid accumulation and the expression of adipogenesis-related genes Pharmaceuticals (Basel). 2022 Sep 28;15(10):1194
Yumm5.2 cells 60 µM 48 hours To test the effect of palmitelaidic acid on tumor cell ferroptosis, results showed that palmitelaidic acid did not significantly enhance tumor cell lipid ROS production or cell death. Cancer Cell. 2022 Apr 11;40(4):365-378. e6
3T3-L1 adipocytes 100 µM 6 days Palmitoleic acid increased the expression of adipocyte differentiation markers such as aP2, Perilipin, and Scl2a4 Pharmaceuticals (Basel). 2022 Sep 28;15(10):1194

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice P. aeruginosa lung infection model Oral 300 mg/kg Once daily for 2 weeks To evaluate the protective effect of PMA against P. aeruginosa lung infection. Results showed that PMA significantly downregulated the expression of QS signals and QS genes, and alleviated neutrophilic airway inflammation. Respir Res. 2024 Dec 2;25(1):423
Mice High-fat diet-induced obesity and NAFLD model Oral gavage 300 mg/kg Once daily for 15 days POA supplementation improved HFD-induced insulin resistance and liver inflammation, reduced hepatic lipid accumulation, and increased the proportion of anti-inflammatory macrophages in the liver. These effects were preserved in myeloid-specific PPAR-γ knockout mice, indicating that the anti-inflammatory effects are independent of PPAR-γ. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Oct;1865(10):158776
C57Bl/6J mice High-fat diet-induced obesity model Oral gavage 300 mg/kg/day Once daily for 4 weeks Palmitoleic acid attenuated high-fat diet-induced body weight gain and adipocyte hypertrophy, increased adipocyte hyperplasia, and reduced the expression of inflammatory genes Pharmaceuticals (Basel). 2022 Sep 28;15(10):1194
C57BL/6N male mice High-fat diet-induced obese mouse model Gavage 600 mg/d/kg Once daily for 6 weeks Palmitoleic acid reduced hepatic gluconeogenesis and the expression of SIRT3 under high-fat diet conditions. Nutrients. 2022 Apr 1;14(7):1482

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03669575 Musculoskeletal Pain Not Applicable Recruiting March 31, 2019 United States, Washington ... More >> Bastyr University Clinical Research Center Recruiting Kenmore, Washington, United States, 98028 Contact: Kate Elliott    425-602-3118    kelliott@bastyr.edu    Contact: Amber Coggings Less <<
NCT03372733 Cardiovascular Disease Phase 2 Recruiting July 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01771224 Inflammatory Bowel Disease ... More >> Ulcerative Colitis Less << Early Phase 1 Unknown December 2014 Mexico ... More >> INCMNSZ Recruiting DF, Tlalpan, Mexico, 14000 Contact: Jesus K Furusho, MD, PhD    +5554870900 ext 2710    kazuofurusho@hotmail.com    Contact: Nallely Bueno, MSc    +5554870900 ext 2712    nallely_bh5@yahoo.com.mx    Principal Investigator: Jesus K Yamamoto, MD, PhD          Sub-Investigator: Nallely Bueno, MSc Less <<
NCT03625427 Obesity Chron... More >>ic Inflammation Less << Not Applicable Not yet recruiting November 2020 United States, North Carolina ... More >> University of North Carolina Nutrition Research Institute Not yet recruiting Kannapolis, North Carolina, United States, 28081 Contact: Jomari Torres, MD    704-250-5062    jomari_torres@unc.edu Less <<
NCT02311790 Insulin Sensitivity Not Applicable Completed - United States, Massachusetts ... More >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.93mL

0.79mL

0.39mL

19.65mL

3.93mL

1.97mL

39.31mL

7.86mL

3.93mL

 

Historical Records

Categories